CALL FOR ABSTRACTS

ABSTRACT SUBMISSION IS CLOSED. REVIEW IN PROGRESS.

 

IMPORTANT DATES:

The call for abstracts closes on 30 June 2026 -> 31 July 2026
The results distributed after 31 July 2026 -> 25 August 2026

TOPICS:

Cutaneous oncology:
–Melanoma
–Non-melanoma skin cancer
–Cutaneous lymphoma

Dermatology and internal medicine:
–Autoimmune connective tissue disorders
–Dermato-endocrinology
–Neurodermatology
–Cardiovascular diseases and skin

Health Policy

Inflammatory skin diseases:
–Acne and hidradenitis suppurativa
–Atopic dermatitis/eczema
–Psoriasis
–Alopecia
–Vitiligo
–Contact dermatitis
–Chronic wounds

Miscellaneous

Teledermatology and AI (Artificial intelligence)

Sexually transmitted infections (STIs)

All abstracts should contain a title, full names and workplace(s) of the author(s), city, country, and email address. The lenght of the abstract, including the title, should not exceed 3000 characters without spaces. Submissions must be in English. Do not use commercial drug names. The names of drugs should be referred to by the active substance.

Abstract structure: 
- Introduction 
- Aims and objectives
- Materials and methods
- Results
- Conclusions
- Key words


Use standard abbreviations where appropriate; any unusual abbreviation should be presented in brackets after the full term when used for the first time in the text. All abstracts will be reviewed. 

Accepted abstracts will be selected for an Oral presentation or a Poster presentation and will be published in the congress abstract book with an ISBN code.

Benefits:
- Free registration for the first author of accepted abstract
- The authors of the two best posters will be nominated and awarded with prizes

HOW TO SUBMIT:

- In order to submit (any number of submissions) you will need to set yourself up as a new user and provide your contact information.
- Select “Submit abstract” to add your submission(s) to the system. The system will prompt you for the required information.
- You will be asked to select a submission topic for your submission.
- You will be asked for your preference of the presentation format – either oral or poster.
- Please submit abstracts only in the Microsoft Word (.docx) version. To view the abstract submission form click HERE
- For abstract submission portal click HERE

AFTER SUBMISSION:

- The online system will enable you to add multiple submissions to your profile.
- All submissions will be acknowledged by email. If you have not received a confirmation of receipt within 5 working days of your submission, please contact the congress secretariat.
- Reviewers will review all abstracts, and their decision on the acceptability of the abstract and the format of the presentation will be final. No correspondence on their decision can be initiated by the author(s).
- An abstract will be reviewed only if the first author of the abstract is registered for the congress.
- Poster presentations will be conducted on-site only.
- Instructions on the duration of the oral presentations and the format of the posters, will be given in the correspondence of the results, which is planned after 25 August 2026. This includes the confirmation of acceptance or decline.
- For poster template, click HERE